Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed Aug 19, 2025 · 10-Q · 50 days after period end · 0001683168-25-006318
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$172.03K | -$293.72K | $19.61K | -$929.63K |
| EPS Diluted | -$0.02 | -$0.04 | $0.00 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 19, 2025 · 50 d after period end
